Comprehensive genomic testing generates powerful results. Inspire your patients to work with their DNA, instead of against it, and achieve the happy and healthy lifestyle they deserve.
Our nutritional genomic and pharmacogenomic test panels provide the foundation for personalized care for each patient—every time.
Sample collection is quick and easy with a simple cheek swab. The DNA is then analyzed in a CLIA and CAP certified lab using our proprietary selection of genes that meet a strict set of criteria, and are clinically validated – an extra step required for testing designed for clinical use.
Each evaluated gene SNP is thoroughly researched for its impact and must be actionable. We do not test genetic mutations or variants that do not meet these criteria.
Safe and secure, the data is protected at every step. Each Ultimate Wellness sample is de-identified before the sample is processed in the lab. Pharmacogenomic samples are required to have patient and ordering physician information per CLIA regulations. We never share or sell data to third parties.
Genomic testing is available only to qualified clinicians. Apply for an account here.
Genomic testing is just the beginning. It requires the skills of a trained clinician to properly interpret and integrate genomic results into a healthcare plan that is personalized and integrated with the whole person. This provides the most value and is the best way to create lifelong results.
Available Genomic Tests
Our Nutritional Genomic test provides the most comprehensive and actionable genomic blueprint available, offering nutrigenomic and nutrigenetic strategies across a wide range of physiological, biochemical, and metabolic systems.
Testing 150 SNPs for gender-specific reports based on more than 404 gene and 1300 variant interpretations, this panel provides a blueprint for prevention and treatment of most chronic diseases. Our in-depth interpretations are accompanied by specific action steps for diet, lifestyle, exercise, and nutritional supplements – plus recommendations for biomarkers to assess the efficacy of your interventions.
As clinicians, we think in biological systems and health conditions – and our reports are organized this way too.
The following are just some of the areas covered in this panel:
Cardiovascular Disease, Lipid Metabolism, Hypertension, Diabetes, Glucose & Insulin Regulation, Bone Health, Osteopenia/Osteoporosis, Detoxification, Estrogen/Hormone Metabolism, Breast/Prostate/Cervical Cancer, Infertility, Neurotransmitters, Depression, Anxiety, Addiction, Stress Response, Cognitive Health, Alzheimer’s, Traumatic Brain Injury (TBI), Autoimmune Disease, Aging, Methylation/Homocysteine, Vitamins A, B, C, D, E, Choline, Iron, Omega Fatty Acids, Calcium, Inflammation, Histamine, Oxidative Stress, Thyroid Function, Weight Management, Exercise, Power vs Endurance, Injury & Recovery, Circadian Rhythm, Migraine & Telomeres.
Adverse drug reactions, over prescribing, under prescribing, and trial-and-error attempts to identify appropriate medications put patients at risk and waste billions of dollars every year.
Pharmacogenomics evaluates genes involved in drug metabolism, transport and elimination to help identify the medications and dosages that will be most effective with minimal risk of negative side effects.
99% of the population carries one gene SNP that can affect medication response, and 89% carry two or more.
A proactive, pharmacogenomic approach helps to identify how an individual may process prescription and over-the-counter medications. These DNA-informed decisions help to identify the right drug at the right dosage—tailored to an individual’s genomic predispositions and specific biochemistry.
This comprehensive pharmacogenomic profile analyzes 44 genes and 372 variants involved in processing over 240 medications, in areas including:
Cancer, Cardiovascular Disease, Diabetes, Gastrointestinal, Gaucher Disease, Infections, Pain, Psychotropic, Rheumatology, Sjogren’s Syndrome, Transplantation and Urologicals.